| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
0.848 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.848 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
DRD2 |
DRD2: D(2) dopamine receptor |
0.848 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
0.848 |
Evidence |
O
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
FGFR3 |
FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor |
0.848 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
0.848 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
LOC643930 |
CCL3L1, D17S1718, G0S19-2, SCYA3L1: Small-inducible cytokine A3-like 1 precursor |
0.848 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
PCDHA2 |
PCDHA2: Protocadherin alpha 2 precursor |
0.848 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
MUCDHL |
MUPCDH, MUCDHL, UNQ2781/PRO7168: Mucin and cadherin-like protein precursor |
0.848 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
CDH6 |
CDH6: Cadherin-6 precursor |
0.848 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.848 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
DRD2 |
DRD2: D(2) dopamine receptor |
0.848 |
Evidence |
|
| SNAP23 |
SNAP23: Synaptosomal-associated protein 23 |
ABI1 |
ABI1, SSH3BP1: Abl interactor 1 |
0.848 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
RICS |
RICS: Rac GTPase activating protein |
0.848 |
Evidence |
|
| RFC1 |
IPI00375359 |
ERF |
ERF: ETS domain-containing transcription factor ERF |
0.848 |
Evidence |
|
| SPI1 |
SPI1: Transcription factor PU.1 |
PAX5 |
PAX5: Paired box protein Pax-5 |
0.848 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.848 |
Evidence |
|
| FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
0.848 |
Evidence |
|